ID1 Randomised Prospective Study Comparing Cost-Effectiveness of Teicoplanin and Vancomycin as Second-Line Empiric Therapy for Infection in Neutropenic Patients
A Dominguez-Gil, M Pérez, L Santos, JF San Miguel, L Vázquez, P Vilches, N Gutierrez, R García-Siaz, D CaballeroVolume:
1
Year:
1998
Pages:
1
DOI:
10.1046/j.1524-4733.1998.1100371.x
File:
PDF, 403 KB
1998